Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-970P is a pseudogene derived from U6 small nuclear RNA (snRNA). U6 snRNA is a highly conserved component of the spliceosome machinery that plays a crucial role in pre-mRNA splicing by catalyzing the excision of introns. The U6 snRNA is the most evolutionarily conserved of all five snRNAs in the spliceosome and sits at the heart of the splicing machinery, coordinating magnesium ions required for splicing chemistry. It forms dynamic secondary structures and undergoes extensive conformational changes during the splicing process, including base-pairing with U4 snRNA initially and then with U2 snRNA to form the catalytically active spliceosome core. While the functional U6 snRNA is essential for proper gene expression, RNU6-970P represents a pseudogene copy that lacks protein-coding potential. Pseudogenes like RNU6-970P may still be transcribed and could potentially have regulatory functions, though their specific biological roles remain largely understudied. The prevalence of U6-derived pseudogenes in vertebrate genomes reflects the evolutionary importance of maintaining functional U6 snRNA copies for organism viability[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA U6 small nuclear 970 pseudogene (RNU6-970P).